AlphaYouAG
Insider selling
Andrew Guggenhime sold Vaxcyte, Inc. (PCVX) stock
Andrew Guggenhime, President And CFO of Vaxcyte, Inc. (PCVX), sold 10,000 shares of PCVX stock, per an SEC Form 4 filed Jul 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Jul 6, 2026.
PCVX has moved +3.4% since the trade date, from $56.96 to $58.92 (Sep 21, 2026 close).
- Traded
- Jul 6, 2026
- Disclosed
- Jul 6, 2026
- Filing delay
- 0 days
- Price since
- +3.4%
- Role
- President And CFO
- Source
- SEC Form 4
More PCVX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.